ArticleArchives of gynecology and obstetrics2026
Short-term maternal outcomes after intraoperative administration of prophylactic oxytocin during cesarean sections: a retrospective cohort study with a comparison of different administration protocols.
Article in Archives of gynecology and obstetrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThe objective of this study was to evaluate the impact of different intraoperative prophylactic oxytocin regimens on maternal blood loss during cesarean section, and to compare effects in procedures performed before versus after onset of labor.
methodsThis retrospective cohort study was conducted at a tertiary care center over 15 years (2006-2021). A total of 1996 cesarean sections were identified, of which 1504 women with complete pre- and postoperative hemoglobin values were included in hemoglobin delta analyses. All 1996 women were considered for descriptive and binary outcome analyses. The study population was stratified into four intraoperative oxytocin exposure groups (0 IU, 3 IU, > 3 up to ≤ 13 IU, and > 13 IU) and further analyzed according to timing before or after onset of labor. The primary outcome was perioperative hemoglobin delta, while secondary outcomes included estimated intraoperative blood loss and binary maternal outcomes such as transfusion, uterine atony, and B-Lynch procedure.
resultsIn cesarean sections before onset of labor, very high intraoperative oxytocin doses (> 13 IU) were associated with significantly increased adjusted blood loss (+ 315 ml, p = 0.007), while intermediate doses (+ 270 ml, p = 0.009) also showed higher losses compared with no oxytocin. Hemoglobin decline was greater in the 3 IU and > 3 up to ≤ 13 IU groups, but not in the > 13 IU group. In cesarean sections after onset of labor, women receiving very high doses likewise had significantly higher blood loss (+ 170 ml, p = 0.004), whereas a modest reduction was observed with 3 IU (- 116 ml, p = 0.014). Estimated blood loss did not reliably correlate with hemoglobin decline, and no consistent dose-response benefit of higher oxytocin administration was observed.
conclusionVery high intraoperative oxytocin doses were not associated with reduced blood loss and were frequently administered in women at increased bleeding risk, suggesting confounding by indication. These results should therefore be regarded as hypothesis-generating rather than definitive evidence to guide prophylactic dosing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.